Prevalence and factors associated with major depressive disorder in children and adolescents at the Uganda Cancer Institute

被引:24
|
作者
Akimana, Benedict [1 ]
Abbo, Catherine [1 ]
Balagadde-Kambugu, Joyce [2 ]
Nakimuli-Mpungu, Etheldreda [1 ]
机构
[1] Makerere Univ, Coll Hlth Sci, Dept Psychiat, POB 7072, Kampala, Uganda
[2] Uganda Canc Inst, Kampala, Uganda
关键词
Depression; Children; Adolescents; Cancer; Uganda; Out-patient; Prevalence; Low-resource; SYMPTOMS;
D O I
10.1186/s12885-019-5635-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe prevalence and factors associated with major depressive disorder (MDD) among adults with cancer have been documented in the scientific literature. However, this data is limited among children and adolescents with cancer; especially in low resource settings such as Uganda. We assessed the prevalence and factors associated with MDD in children and adolescents attending the Uganda cancer institute out-patient clinic.MethodsThis was a cross-sectional study in which three hundred and fifty-two children and adolescents with any cancer diagnosis were screened for depression using the Child Depression Inventory (CDI) and evaluated with the mini neuropsychiatric interview for children and adolescents (MINI-KID). Associated factors were assessed using a standardized questionnaire that assessed child and caregiver demographic and psychosocial characteristics. Multiple logistic regression models were used to assess factors independently associated with MDD.ResultsOf the 352 children and adolescents recruited in the study 134(38%) scored above a cut-off point of 13 on the CDI indicating significant depression symptoms. However, 91(26%) met criteria for MDD. The majority of those with MDD (n=59 64.8%) had CDI scores of 13-19 indicating mild depression, 30(33%) had scores of 20-25 indicating moderate depression and 2(2.2%) had scores of 25 and above indicating severe depression. Protective factors against MDD were having a special person in the respondent's life (p=0.002) and using self-distraction as a coping method (p=<0.001). Risk factors were being an adolescent(p=<0.001).ConclusionThe prevalence of MDD is substantial in children and adolescents with cancer in Uganda. Given that the majority had a mild-moderate depression, there is an urgent need to integrate psychotherapy-the first-line treatment for depression into the routine care of children and adolescents with cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Predictors and Moderators of Relapse in Children and Adolescents With Major Depressive Disorder
    Kennard, Beth D.
    Mayes, Taryn L.
    Chahal, Zohra
    Nakonezny, Paul A.
    Moorehead, Alexandra
    Emslie, Graham J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2018, 79 (02)
  • [32] Trajectories of suicidal ideation in children and adolescents with major depressive disorder
    Haeberling, Isabelle
    Bachmann, Silja
    Smigielski, Lukasz
    Emery, Sophie
    Albermann, Mona
    Strumberger, Michael
    Baumgartner, Noemi
    Schmeck, Klaus
    Walitza, Susanne
    Berger, Gregor
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (12)
  • [33] Executive Functioning in Children Versus Adolescents with Major Depressive Disorder
    Rodriguez, M.
    West, S.
    Golden, C.
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2010, 25 (06) : 488 - 488
  • [34] Major Depressive Disorder in Children and Adolescents After Renal Transplantation
    Ghanizadeh, A.
    Mansoori, Y.
    Ashkani, H.
    Fallahzadeh, M. H.
    Derakhshan, A.
    Shokrpour, N.
    Akhondzadeh, S.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1627 - 1629
  • [35] THE USE OF RDC CRITERIA FOR MAJOR DEPRESSIVE DISORDER IN CHILDREN AND ADOLESCENTS
    PUIGANTICH, J
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1982, 21 (03): : 291 - 293
  • [36] Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder
    Mathews, M
    Mathews, M
    Mathews, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (01): : 40 - 40
  • [37] Recent developments in the treatment of major depressive disorder in children and adolescents
    Hussain, Haseena
    Dubicka, Bernadka
    Wilkinson, Paul
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2018, 21 (03) : 101 - 106
  • [38] Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder
    Findling, Robert L.
    Groark, James
    Chiles, Deborah
    Ramaker, Sara
    Yang, Lingfeng
    Tourian, Karen A.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (04) : 201 - 209
  • [39] A comparison of the response to sertraline in children and adolescents with major depressive disorder
    Donnelly, CL
    Ambrosini, P
    Wagner, KD
    Rynn, M
    Landau, P
    Wohlberg, CJ
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (04) : 418 - 419
  • [40] What is new in bipolar disorder and major depressive disorder in children and adolescents - Preface
    Carlson, GA
    Kashani, JH
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2002, 11 (03) : XV - XXII